GOZZETTI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 258
AS - Asia 143
EU - Europa 141
AF - Africa 12
SA - Sud America 2
Totale 556
Nazione #
US - Stati Uniti d'America 257
CN - Cina 49
SG - Singapore 48
GB - Regno Unito 41
VN - Vietnam 30
SE - Svezia 22
DE - Germania 19
IT - Italia 19
IE - Irlanda 16
IN - India 9
BG - Bulgaria 6
RU - Federazione Russa 5
TG - Togo 5
EE - Estonia 4
FR - Francia 4
ZA - Sudafrica 4
TR - Turchia 3
UA - Ucraina 3
CI - Costa d'Avorio 2
JO - Giordania 2
AT - Austria 1
CA - Canada 1
CL - Cile 1
EC - Ecuador 1
IR - Iran 1
LB - Libano 1
NG - Nigeria 1
NL - Olanda 1
Totale 556
Città #
Singapore 45
Southend 37
Chandler 32
Dong Ket 30
Fairfield 28
Santa Clara 25
Ashburn 18
Wilmington 18
Dublin 16
Houston 16
Woodbridge 13
Cambridge 12
Princeton 10
Seattle 10
Boardman 8
Sofia 6
Bremen 5
Lomé 5
Ann Arbor 4
Beijing 4
Changsha 4
Jinan 4
San Diego 4
Westminster 4
Nanjing 3
Padova 3
Saint Petersburg 3
Shenyang 3
Verona 3
Abidjan 2
Amman 2
Ankara 2
Bologna 2
Guangzhou 2
Hebei 2
Hyderabad 2
New York 2
Shanghai 2
Siena 2
Zhengzhou 2
Abeokuta 1
Beirut 1
Berlin 1
Boydton 1
Chengdu 1
Des Moines 1
Haikou 1
Hwang Chow 1
Istanbul 1
Jiaxing 1
Kilburn 1
Kuban 1
Kunming 1
Langfang 1
Los Angeles 1
Milan 1
Nanchang 1
Ottawa 1
Phoenix 1
Qingdao 1
Quito 1
Shenzhen 1
Shijiazhuang 1
Taiyuan 1
Taizhou 1
Turin 1
Wuhan 1
Zanjan 1
Totale 423
Nome #
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. 151
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia 115
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 107
Residual peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 99
null 39
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation 25
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 23
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 13
Totale 572
Categoria #
all - tutte 1.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 0 0 0 13 15 19 7 11 9
2020/202169 10 5 3 0 0 0 3 2 5 4 2 35
2021/202273 4 4 2 2 5 6 2 8 3 6 13 18
2022/2023115 9 20 4 17 9 7 2 5 27 4 5 6
2023/202431 0 6 3 1 6 11 1 2 0 0 1 0
2024/2025127 10 50 18 12 27 10 0 0 0 0 0 0
Totale 572